Close

Barclays Maintains an 'Overweight' on Rigel Pharmaceuticals (RIGL); Update from Management Meeting Apr 11, 2011 01:49PM
Barclays Reiterates an 'Overweight' on Rigel Pharmaceuticals (RIGL); OSKIRA Trials on Track with OLE Data at ACR; Update on R343 Dev. Status Next Mar 2, 2011 01:45PM
Barclays Gets Bullish On US Biotechnology Sector (BBH) May 20, 2009 01:12PM